baber/WOPTO huggingface dataset:
Patent NZ-556503-A (NZ)
Title: Systems, methods and software for distributed loading of databases
Inventor: BLUHM MARK
IPC: G06F17/30
Filed: 2006-01-09
Abstract: An information retrieval system comprises a queue for storing load data requests; a set of two or more load servers for retrieving data from a queue and indexing documents for retrieval based on the data retrieved from the queue; and first and second load monitors for monitoring operation of the load servers and providing new data on the queue accessible by the load servers, with the first load monitor configured to provide information regarding its operations to the second load monitor, and the second load monitor configured to respond to status information indicating failure of the first load monitor to take over monitoring of the load servers and providing new data on the queue. Each load server is associated with a service-level-agreement data structure, the data structure including a first field for indicating a minimal priority of document indexing requests that the load server is permitted to accept. The data structure includes a second field for identifying for which databases the load server is permitted to index documents; and the data structure includes a third field indicating a temporal aspect.
Patent NZ-560486-A (NZ)
Title: Recognition system for an apparatus that delivers breathable gas to a patient
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/00
Filed: 2006-02-24
Abstract: An adapter for use with a flow generator includes a conduit (16) attachable to the outlet (24) of the flow generator (14) and an identifying element (46) supported by the conduit and providing an identifying feature unique to a specific peripheral component attachable to the flow generator. The identifying feature is communicatable to the flow generator so that appropriate operating parameters of the flow generator may be automatically selected by the flow generator to coordinate with the specific peripheral component.
Patent NZ-561244-A (NZ)
Title: Process for preparing 2,3-disubstituted indoles
Inventor: KHODABOCUS AHMAD
IPC: C07D401/04
Filed: 2006-02-10
Abstract: Disclosed is a process for making 2, 3 disubstituted indole compounds of general formula (I), which comprises which comprises the steps of: (a) forming a compound of formula (ii) from a bromoindole compound (i), either by reaction thereof with a dialkoxyl C1-5 borane in the presence of a ligand, a palladium catalyst and a base, or by reaction thereof with a trialkyl magnesiate reagent, followed by treatment with a borate; and (b) reacting the product of step (a) with a R2-Hal, wherein Hal is Br or I, and all the other variables are as defined in the specification.
Patent NZ-561378-A (NZ)
Title: Tub cabinet
Inventor: WILSON GARETH SCOTT
IPC: D06F1/00
Filed: 2007-09-11
Abstract: A tub cabinet comprising: at least one drawer in a vertical front face of the tub cabinet; at least one container removable from the tub cabinet, the container being located within the at least one drawer by: at least one side drawer member to contact at least one side edge of the container; a rear drawer member to contact a further side edge of the container; and a front drawer member to contact a further side edge of the container.
Patent NZ-567131-A (NZ)
Title: Tumor angiogenesis associated genes and a method for their identification using HMGB1 inhibitors
Inventor: GRIFFIOEN ARJAN WILLEM
IPC: C07K14/82
Filed: 2006-09-29
Abstract: Disclosed is an in vitro method to identify candidate drugs for treating a patient having a pathological condition or a susceptibility to a pathological condition. The disclosed method comprises: i. contacting a test agent with recombinant host cells transfected with an expression construct which encodes for a specific sequence, as defined in the specification, including parts thereof, where said part has an amino acid sequence at least 70% identical to said specific sequence; ii. determining the amount of proliferation of said cells; iii. identifying a test agent as a candidate drug for treating patients having a pathological condition or a susceptibility to a pathological condition if it modulates the proliferation of said cells.
Patent NZ-575550-A (NZ)
Title: Rifaximin
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: C07D498/22
Filed: 2007-09-24
Abstract: Disclosed is a process for manufacturing amorphous rifaximin comprising a) reacting Rifamycin S with 2-amino-4-picoline in presence of suitable solvent b) adding iodine dissolved in suitable solvent to the above reaction mass followed by reducing agent c) adjusting the pH of the reaction mass between 1.5 - 2.5 under stirring d) extracting with water immiscible organic solvent and concentrating the organic layer to form a residue e) stripping the residue obtained in step d) with a water immiscible solvent or mixture of water immiscible solvents to residue. f) stirring the residue obtained in step e) with a water immiscible solvent or mixtures thereof to get a solid g) Filtering the solid and washing with the same solvent/s and h) drying the solid at a temperature below 40 degrees C.
Patent NZ-577640-A (NZ)
Title: Adjustments of iub load measurements
Inventor: ENGLUND EVA
IPC: H04B17/00
Filed: 2008-02-01
Abstract: A method and a device for providing load measurement and resource management in network are disclosed. The device comprises a memory to store instructions and a processor to execute the instructions to determine whether a discrepancy relating to scheduling headroom exists between the device and another device, modify a power measurement associated with an interface shared between the device and the other device if it is determined that the discrepancy exists and provide the other device with a modified power measurement. Further disclosed is a device comprising a memory to store instructions, and a processor to execute the instructions to receive one or more load measurements and effective cancellation interference information associated with a scheduling headroom discrepancy determination; modify the one or more load measurements based on the effective cancellation interference information, and calculate a scheduling headroom based on the modified one or more load measurements.
Patent NZ-582045-A (NZ)
Title: A pharmaceutical composition comprising at least 10mg/mL of alfa mannosidase and less that 5% total protein aggregates
Inventor: NILSSON STEPHEN
IPC: C07K1/34
Filed: 2007-04-04
Abstract: Disclosed is a pharmaceutical composition comprising at least 10 mg/ml of a polypeptide alfa mannosidase or functionally equivalent parts thereof or a polypeptide being a functionally equivalent analogue of alpha mannosidase, wherein less than 5% of the total amount of the polypeptide in said composition is present in the form of aggregates. Further disclosed is a pharmaceutical composition comprising 75-250 mg/ml of a polypeptide alfa mannosidase or functionally equivalent parts or functionally equivalent analogues thereof, wherein less than 5% of the total amount of the polypeptide in said composition is present in the form of aggregates, for use as a medicament for the treatment of alfa mannosidosis.
Patent NZ-582676-A (NZ)
Title: Methods for n-demethylation of morphine and tropane alkaloids
Inventor: CARROLL ROBERT
IPC: C07D489/02
Filed: 2008-06-30
Abstract: Disclosed is a one pot method for the N-dementhylation fo a tertiary N-methylate heterocycle comprising mixing the teriary N-methylated heterocycle with a metal catalyst in the presence of an oxidizing agent, wherein the metal catalyst is Pd(OAc)2 (Palladium (II) acetate).
Patent NZ-584102-A (NZ)
Title: Multiply redundant blowout preventer for an oil well
Inventor: MCGRATH SCOTT PHILLIP
IPC: E21B33/06
Filed: 2008-09-19
Abstract: Disclosed is a Blow Out Preventer (BOP) fluid supply apparatus providing additional hydraulic liquid operational redundancy of the BOP function. The apparatus comprises a main source of hydraulic fluid; a primary component assisting in operating a BOP function; a BOP function. A primary fluid flow route from the main source of hydraulic fluid passes through the primary component assisting in operating the BOP function, through a first valve, through a second valve, and then to the BOP function. A secondary fluid flow route from a source of hydraulic fluid originates downstream of the primary component assisting in operating the BOP function leading to an isolation valve rigidly fixed to the BOP, then on through a pilot-operated hot spare valve rigidly fixed to the BOP, through a hose removably connected to an intervention panel The secondary fluid flow route then passes through the second valve, and to the BOP function, wherein the secondary fluid flow route bypasses the primary component assisting in operating the BOP function and the first valve and provides hydraulic fluid to operate the BOP function. The primary and secondary fluid flow routes pass through a regulator. The pilot-operated valve is controllable at a surface station and obtains hydraulic fluid for pilot operation from a hot spare source on the BOP.
Patent NZ-586452-A (NZ)
Title: 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof and medicinal products containing the derivative
Inventor: KLAR ULRICH
IPC: A61K31/58
Filed: 2008-12-23
Abstract: Disclosed are 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid g-lactone derivatives and their solvates, hydrates, stereoisomers and salts, as represented by the general formula (I), in which Z is selected from the group comprising oxygen, two hydrogen atoms, NOR' and NNHSO2R'; R4 is selected from the group comprising hydrogen, fluorine, chlorine or bromine; R18 is hydrogen or alkyl; and wherein the remaining substituents are as defined herein. Representative compounds as disclosed herein include 17b-hydroxy-15a,16a-methylene-19-nor-17a-pregna-4,20(Z)-dien-3-one-21-carboxylic acid g-lactone, 17b-hydroxy-7a-cyclopropyl-15b,16b-methylene-19-nor-17a-pregna-4,20(Z)-dien-3-one-21-carboxylic acid g-lactone and 17a-pregna-4,20(Z)-dien-3-one-21-carboxylic acid g-lactone. Further disclosed is a medicinal product (such as an intrauterine system (IUS)) which contains at least one 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid g-lactone derivative as defined above and at least one suitable pharmaceutically harmless additive for oral contraception or for the treatment of pre-, peri- and postmenopausal complaints.
Patent NZ-594944-A (NZ)
Title: Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870
Inventor: MASIGNANI VEGA
IPC: C07K14/22
Filed: 2006-11-27
Abstract: NMB 1870 is a protein in Neisseria meningitidis. Three families of NMB 1870 are known. To increase the ability of a NMB 1870 protein to elicit antibodies that are cross-reactive between the families, NMB 1870 is engineered. Sequences can be substituted from one NMB 1870 family into the corresponding position in another family. Proteins of NMB 1870 sequences from different families can be joined to each other.
Patent NZ-596947-A (NZ)
Title: Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
Inventor: BOGDANOWICZ PATRICK
IPC: A61P29/00
Filed: 2010-06-08
Abstract: IP No. 596947 The present disclosure relates to a compound with the following general formula (I): in which: R1 is a hydrocarbon chain of an unsaturated fatty acid from C12 to C24 including at least one unsaturation; and R2 and R3 are, independently or simultaneously: a hydrogen or a C1-C3 alkyl or a phenyl; and R4: a hydrogen atom or COR1’, where R1’ is a hydrocarbon chain of an unsaturated fatty acid from C12 to C24 including at least one unsaturation, advantageously 1 to 6 and preferably 1 to 4. Also disclosed are compositions of the compounds and their use in depigmenting the skin and/or head hair and/or body hair, for the treatment and/or prevention of skin ageing, for hydrating the epidermis, for stimulating re–growth of head and/or body hair, or for the treatment of skin inflammation.
Patent NZ-598359-A (NZ)
Title: Locking cover for a vessel having a neck, including a cap having attachment tabs
Inventor: BELLE GUILLAUME
IPC: A61J1/00
Filed: 2010-08-25
Abstract: Disclosed is a locking cover (1) for a vessel (2) having a neck (3), intended to fix a stopper (4) in the neck (3) of the vessel (2). The disclosure notes that locking covers are useful in medical applications to prevent irreversible separation of a cap from a cover. The locking cover (1) comprises a cage (6) with locking tabs (8, 9) that is configured to surround the stopper (4) and the neck (3) and to lock them in position relative to each other in a given axial direction (A). A ring (7) is fastened around the cage (6) and is configured with a central aperture (17) that preserves access from outside the cover (1) to the inside of the vessel (2) by way of the stopper (4). A cap (23) is configured to close the aperture (17). The cap (23) has a flat head large enough to cover the aperture (17) and attachment tabs (25) that project substantially perpendicularly relative to the head. The attachment tabs (25) are spaced apart along the annular periphery of the aperture of the ring (7) and are gripped as in a vice between the ring (7) and the cage (6).
Patent NZ-599535-A (NZ)
Title: Hose end fitting having connection flange and flexible extension
Inventor: ZANDIYEH ALI REZA KAMBIEZ
IPC: F16L11/08
Filed: 2009-01-22
Abstract: A hose end fitting (38) including a tubular member (40) having a first end (42) arranged to be located within a hose and a second end (44) with a connection flange (46) provided at the second end. A flexible extension (70) is provided at the first end of the fitting. The flexible extension decreases in thickness towards its free end.
Patent NZ-599840-A (NZ)
Title: Sequence dependent aggregation
Inventor: KETTENBERGER HUBERT
IPC: C07K16/00
Filed: 2010-12-17
Abstract: Disclosed is a for providing a nucleic acid sequence encoding an immunoglobulin comprising the following steps a) aligning the amino acid sequence of the fourth heavy chain framework region of an immunoglobulin with the reference sequence xxxxTxxTxxx, wherein each x is as defined in SEQ ID NO: 11, to achieve maximal level of amino acid sequence identity, b) identifying aligned amino acid positions with a small hydrophobic or non-polar amino acid residue at position 5 and/or 8 in the fourth heavy chain framework region, c) modifying the immunoglobulin by substituting an amino acid residue in the fourth heavy chain framework region at a position identified in b), which is threonine in the reference sequence and which is not threonine in the fourth heavy chain framework region, for the respective threonine residue as in the reference sequence, d) providing a nucleic acid sequence encoding the immunoglobulin. Further disclosed is a method for producing an immunoglobulin by cultivating a cell comprising a nucleic acid sequence as disclosed above and recovering the produced immunoglobulins.
Patent NZ-600913-A (NZ)
Title: Heat Transfer Enhancing Agent comprising a nano-scale powder and micro-scale powder
Inventor: HUANG YEN-HAO
IPC: B82Y99/00
Filed: 2012-06-26
Abstract: 600913 Disclosed herein is an agent when used in a heat-transfer fluid of a heat exchange system or a coolant of a cooling system, for enhancing the heat conductivity thereof, comprising a nano-scale powder of a first material and a micro-scale powder of a different second material, wherein each particle of the nano-scale powder having a particle size smaller than 100 nanometers, and each particle of the micro-scale powder having a particle size between 100 nanometers and 500 micrometers. The material may be selected from a group consisting of: a metal, an alloy, a non-metallic material, a metallic compound, and a non-metallic compound wherein: the metal is selected from the group consisting of: titanium, vanadium, chromium, cobalt, nickel, iridium, zirconium, niobium, molybdenum, rhodium, palladium, tantalum, tungsten, platinum, silver and gold; the metallic compound is substantially a transition metal oxide such as a transition metal oxide selected from the group consisting of: titanium oxide (TiO2), cooper oxide, iron oxide, and molybdenum oxide (MoO2); or the metallic compound is substantially a transition metal oxide such as an alkaline earth metal compound, such as magnesium oxide (MgO). the metallic compound is substantially an oxide of a metal belonging to group 13 of the periodic table, such as aluminium oxide (Al2O3) the non-metallic compound is a material selected from the group consisting of: carbon and graphite. Additionally wherein the agent is doped with another components selected from the group consisting of: a dispersant, a suspending agent, a coloring agent, bacteriostatic agent and water.
Patent NZ-600951-A (NZ)
Title: Preservative formulation for cellulose containing materials
Inventor: KRAUS ALEXANDER
IPC: A01N59/20
Filed: 2010-12-13
Abstract: A formulation is disclosed, which contains at least one protective substance that is active with respect to cellulose-containing materials, such as wood-containing building materials in the form of solid wood or wood-based materials, and at least one specific compound with dispersing properties. The protective substance consists essentially of a copper compound in particle form with a particle size in a range of from 1 nanometer to 1 micrometer and the dispersants are branched comb-shaped polymers with polyether side chains, naphthalene-sulfonate-formaldehyde condensation products, melamine-sulfonate-formaldehyde condensation products and phosphatized polycondensation products. The formulations disclosed are suitable in particular as plant protection agents and wood preservatives and are preferably used in the form of suspensions for pressure treatment of the respective building materials.
Patent NZ-607879-A (NZ)
Title: Mask system
Inventor: FORMICA JUSTIN JOHN
IPC: A61M16/06
Filed: 2011-09-30
Abstract: A mask system for delivery of respiratory therapy to a patient includes a nares portion (20) and a mouth portion (40) and an inlet conduit (5) connected to at least one of the nares portion and the mouth portion to deliver the pressurized, breathable gas. The mouth portion includes a mouth chamber and a mouth sealing portion adapted to form a seal with the patient’s mouth. The mouth chamber includes an opening adapted to selectively receive the pressurised, breathable gas. The nares portion is adapted to form a seal with the patient’s nares. The mask system is adapted to selectively utilize the nares portion and/or the mouth portion. In a first mode the mask system utilizes both the nares portion and the mouth portion, and in a second mode utilizes the nares portion and doesn’t utilize the mouth portion.
Patent NZ-616038-A (NZ)
Title: Hinge device for doors, shutters or the like
Inventor: BACCHETTI LUCIANO
IPC: E05F3/20
Filed: 2012-04-05
Abstract: Disclosed is a hinge device for rotatably moving a closing element. The hinge device comprises a fixed element (11) anchorable to a stationary support structure coupled to a movable element (10) which is anchorable to the closing element for rotating around a first longitudinal axis (X) between an open position and a closed position. The hinge device further includes at least one slider (20), telescopically coupled to a pivot (40), movable along the longitudinal axis between a compressed and an extended position. The pivot (40) and the slider (20) are reciprocally coupled so that to the rotation of the movable element (10) around the first axis corresponds the sliding of the slider along the longitudinal axis and vice versa. The pivot includes a cylindrical portion (42) having at least one pair of substantially equal helical grooves angularly spaced 180° to define a guide element. A first end (22) of the slider comprises a first pin (25) insertable through the guide element. A counteracting elastic means (50), such as a spring, acts on the slider for the automatic returning thereof from one of a compressed or extended position toward the other of the compressed or extended positions. The slider further includes a plunger element movable in a working fluid chamber, including a working fluid. The plunger element divides the working fluid chamber into a first variable volume chamber and a second variable volume chamber which are in fluid communication via a through opening in a pushing head of the plunger element. Valve means are provided in the through opening to allow the passage of the working fluid between the first variable volume chamber and the second variable volume chamber during one of the opening and closing of the closing element and to prevent the backflow thereof during the other of the opening and the closing of the same closing element. A hydraulic circuit is provided, at least partially in the hinge body. The hydraulic circuit has at least one opening located in the second variable volume chamber and furthermore at least one first opening and at least one second opening in the first variable volume chamber. Each of these openings is fluidly connected in the hydraulic circuit. The plunger element is further provided with a cylindrical rear portion. During a stroke of the plunger element, the cylindrical rear portion blocks the second opening until a final second part of the stroke. During the final second part, the cylindrical rear portion unblocks the second opening and subsequently imparts a latching action on the movable element. The hinge body further includes at least one first adjustment screw and at least one second adjustment screw which interacts with the first opening and at least one second opening, respectively, in the first variable volume chamber. The first and second adjustment screws are operable by a user from the outside to adjust the flow speed of the working fluid and the force by which the closing element latches.
Patent NZ-619186-A (NZ)
Title: Excess pressure safety relief valve
Inventor: CRICHTON DAVID GORDON ARTHUR
IPC: F16K31/18
Filed: 2012-12-21
Abstract: 619186 A liquid pressure control valve includes at least one O-ring seal (11) mounted, in a first sealing position, on a sealing section of a first component thereof to seal a junction between that first component (16) and a second component (1b) which junction controls a bleed passage (9) between. The first component is threadingly engaged within the second component. The valve includes a chamber intended to contain liquid up to a required pressure during operation of the valve. The valve includes at least one annular impingement element (20) mounted about a reduced diameter section, relative to the sealing section, of the first component and adjacent thereto with the impingement element. The impingement element includes a bore that tapers away from the O-ring seal, whereby with a pressure in excess of the required pressure acting on the O-ring it will be compressed, at least partly, into the bore of the impingement element and away from the o ring’s first sealing position to take up a second non-sealing position (as shown). With release of the excess pressure the O-ring returns to its first sealing position. In the second non-sealing position the fluid is released through an entrance (21), up through the bleed passage (9) formed by the interstice gap of the threaded connection, and out through the exit aperture (22), thereby relieving the excess pressure.
Patent NZ-630359-A (NZ)
Title: Methods and systems for sending bills from a biller to a payer
Inventor: KEITH ROBERT GODING BROWN
IPC: G06Q20/14
Filed: 2014-04-11
Abstract: Disclosed is a computer implemented method for sending bills from a biller to a payer. A billing service system receives a communication address and billing data from the biller. The billing service system then determines a payer identifier and a payer institution based on the communication address. The billing service system sends the billing data associated with the payer identifier and a registration confirmation message comprising the payer identifier, the customer identifier and the biller identifier to the determined payer institution.